drugset / Trial / NCT04802837
Safety, Tolerability and the Pharmacokinetics of Ridinilazole in Adolescent Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Study to evaluate the safety of ridinilazole in adolescent subjects and how ridinilazole is metabolized.
Timeline
- Start
- 2021-05-19
- Primary completion
- 2021-09-17
- Completion
- 2022-09-28
Outcome
Outcome not reported
Stopped: “SMT19969-C006 study was terminated in alignment with corporate decision to pursue further development of drug candidate with a partner.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ridinilazole | Small molecule | 200 mg | — |
| Comparator | Vancomycin | Other / unclassified | 125 mg | — |